ArticleScientific reports2025
Ziziphus spina-christi alleviates paracetamol-induced hepatorenal toxicity in rats through in vivo and computational approaches.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Zingerone Alleviates Acetaminophen-Induced Liver Damage by Regulating Oxidative Stress, Inflammation, Apoptosis, Endoplasmic Reticulum Stress, and Autophagy.Journal of biochemical and molecular toxicology · 2026Article
- Deep ensemble learning with transformer models for enhanced Alzheimer's disease detection.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Paracetamol (PCM) overdose is a leading cause of drug-induced liver and kidney injury, necessitating effective therapeutic strategies. This study aimed to evaluate the protective effects of Ziziphus spina-christi (ZSC), a traditional medicinal plant with documented antioxidant and protective properties against PCM-induced hepatorenal toxicity in rats, integrating both in vivo and computational approaches. Male rats were divided into four groups: control (vehicle), PCM (300 mg/kg), ZSC (400 mg/kg), and PCM + ZSC (combined treatment). Treatments were administered daily for 14 days. The study included biochemical analysis of liver and kidney function markers, oxidative stress indicators, histological and immunohistochemical examinations, and molecular docking studies. Statistical significance was determined using one-way ANOVA followed by post hoc tests. PCM administration caused significant increases in liver enzymes, lipid profile, renal markers, and hepatic oxidative stress. It also upregulated the expression of apoptotic proteins (Bax, caspase-3, ERK, JNK, and p38 MAPK) and inflammatory mediators (TNF-α, NF-κB), while downregulating the anti-apoptotic protein Bcl-2. Co-treatment with ZSC significantly reversed these alterations, improving biochemical, histological, and molecular parameters. Molecular docking showed that rosmarinic acid, a major phenolic acid in ZSC, had strong binding affinities with the studied apoptotic and inflammatory targets through various hydrophilic and hydrophobic interactions. ZSC demonstrates significant protective effects against PCM-induced liver and kidney damage, likely through modulation of apoptotic and inflammatory signaling pathways including NF-κB/TNF-α, Bcl-2/Bax/caspase-3, and ERK/JNK/p38 MAPK. These findings support the potential of ZSC as a therapeutic candidate for managing drug-induced hepatorenal toxicity and provides the foundation for clinical testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.